Inactive Instrument

Other languages Taiwan Liposome Company, Ltd. Nasdaq

Equities

Endo Ventures Limited Executes Agreement with Taiwan Liposome Company, Ltd. to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain	22-06-13
TLC BioSciences Announces Publication of Tlc599 Phase Ii Results in Arthritis Research & Therapy	22-03-07
Taiwan Liposome : to Voluntary Delist From Nasdaq	21-09-08
Taiwan Liposome : Working With Zydus Healthcare to Provide Supply of AmphoTLC in India	21-05-26
Taiwan Liposome : TLC Secures India's Approval For Mucormycosis Treatment AmphoTLC	21-05-25
Taiwan Liposome Company, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13
Taiwan Liposome Company, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-04
Sector Update: Health Care Stocks Flat During Premarket Trading on Monday	20-12-28
Taiwan Liposome : Completes Patient Enrollment in Study of TLC599 in Patients With Osteoarthritis Knee Pain	20-12-28
Taiwan Liposome : Reports 98% Enrollment of Phase 3 Study of Osteoarthritis Drug	20-12-18
Taiwan Liposome Company, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-27
Taiwan Liposome Company, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-04

No results for this search